Patents by Inventor Yidong MA

Yidong MA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PD-L1/LAG-3 BISPECIFIC ANTIBODY FORMULATION AND PREPARATION METHOD THEREFOR AND USE THEREOF
    Publication number: 20230287124
    Abstract: The present invention relates to a formulation comprising a PD-L1/LAG-3 bispecific antibody, and particularly to a pharmaceutical formulation comprising a PD-L1/LAG-3 bispecific antibody, a buffer, a stabilizer, a surfactant and a chelating agent. Furthermore, the present invention further relates to therapeutic or prophylactic use of these formulations.
    Type: Application
    Filed: July 22, 2021
    Publication date: September 14, 2023
    Inventors: Tianyi YAO, Yidong MA, Yinjue WANG
  • FORMULATION COMPRISING ANTI-PD-1/HER2 BISPECIFIC ANTIBODY, METHOD FOR PREPARING SAME AND USE THEREOF
    Publication number: 20220281972
    Abstract: The present invention relates to formulations comprising an anti-PD-1/HER2 bispecific antibody, and in particular to a pharmaceutical formulation comprising the anti-PD-1/HER2 bispecific antibody, a buffer, a stabilizer and a surfactant. Furthermore, the present invention also relates to therapeutic or prophylactic use of these formulations.
    Type: Application
    Filed: August 6, 2020
    Publication date: September 8, 2022
    Inventors: Yanghan LIU, Yidong MA, Yinjue WANG, Kaisong ZHOU
  • FORMULATION COMPRISING ANTI-LAG-3 ANTIBODY, METHOD FOR PREPARING SAME AND USE THEREOF
    Publication number: 20220251188
    Abstract: The present invention relates to formulations comprising an anti-LAG-3 antibody, and in particular to pharmaceutical formulations comprising an antibody specifically binding to LAG-3 molecules, a buffer, a stabilizer and a surfactant. Furthermore, the present invention also relates to therapeutic or prophylactic use of these formulations.
    Type: Application
    Filed: June 24, 2020
    Publication date: August 11, 2022
    Inventors: Tianyi YAO, Yidong MA, Yinjue WANG, Kaisong ZHOU
  • FORMULATION COMPRISING ANTI-CD47/PD-L1 BISPECIFIC ANTIBODY, METHOD FOR PREPARING SAME AND USE THEREOF
    Publication number: 20220251210
    Abstract: The present invention relates to formulations comprising an anti-CD47/PD-L1 bispecific antibody, and in particular to pharmaceutical formulations comprising an anti-CD47/PD-L1 bispecific antibody, a buffer, a stabilizer and a surfactant. Furthermore, the present invention also relates to therapeutic or prophylactic use of these formulations.
    Type: Application
    Filed: June 24, 2020
    Publication date: August 11, 2022
    Inventors: Xinggui ZHU, Yidong MA, Yinjue WANG, Kaisong ZHOU